Hair Loss in Cancer Chemotherapy Patients

In a study conducted 16 years ago, the hair loss of 8 cancer patients aged between 18 and 60 years undergoing chemotherapy was examined. All patients experienced moderate diffuse alopecia within 1 month of starting treatment. Among the 8 patients, 3 had only telogen hairs and 3 had a high count of dystrophic hairs. The study concluded that both anagen and telogen effluvium are implicated in hair loss in cancer patients on chemotherapy.